Parallel Bio develops tools that help in the discovery and development of immunotherapies.
Parallel Bio has raised $21.0M in total funding. The most recent round was Series A. The last funding was announced in June 2025.
Parallel Bio's investors include Y Combinator, AIX Ventures, Amplo, Breakout Ventures, Refactor.
Parallel Bio is headquartered in Watertown, United States.
Parallel Bio develops tools that help in the discovery and development of immunotherapies.
Parallel Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Parallel Bio — Funding & Investors." VCBacked, June 11, 2025, https://www.vcbacked.co/company/parallel-bio. Accessed September 16, 2026.
VCBacked. (2025). Parallel Bio — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/parallel-bio
{{cite web |title=Parallel Bio — Funding & Investors |url=https://www.vcbacked.co/company/parallel-bio |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated